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Abstract
Background: Due to the progressive nature of dementia, it is important to understand links between disease
severity and health-related outcomes. The aim of this study is to explore the relationship between disease severity
and the quality of life (QoL) of people with dementia and their family carers using a number of disease-specific and
generic measures.
Methods: In the MODEM cohort study, three-hundred and seven people with clinically diagnosed dementia and
their carers were recruited on a quota basis to provide equal numbers of people with mild (standardised Mini-
Mental State Examination (sMMSE), n = 110), moderate (sMMSE 10–19, n = 100), and severe (sMMSE 0–9, n = 97)
cognitive impairment. A series of multiple regression models were created to understand the associations between
dementia severity and the QoL of people with dementia and the QoL of their carers. QoL was measured using self-
(DEMQOL, EQ-5D, CASP-19) and proxy-reports (DEMQOL-Proxy, EQ-5D) of disease-specific and generic QoL of the
person with dementia. Carer generic QoL was measured by self-report (EQ-5D, SF-12).
Results: Disease severity, as measured by the sMMSE, was not significantly associated with the QoL of the person
with dementia or the carer (p > 0.05), even after controlling for potential confounding variables for self-reported
instruments. Proxy measures (rated by the carer) differed systematically in that there were small, but statistically
significant proportions of the variance of QoL was explained by severity of cognitive impairment in multiple
adjusted models. We also found little in the way of statistically significant relationships between the QoL of people
with dementia and that of their carers except between DEMQOL-Proxy scores and the carer EQ-5D scores and carer
SF-12 mental sub-scores.
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Conclusions: The data generated supports the somewhat counterintuitive argument that severity of cognitive
impairment (and therefore severity of dementia) is not associated with lower QoL for the person with dementia
when self-report measures are used. However, in absolute terms, as judged by the variance in the multivariate
models, it is clear that the contribution of dementia severity to the QoL of people with dementia is minimal
whatever the measurement used, be it self- or proxy-rated, or disease-specific or generic.
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Background
Dementia is a progressive neurodegenerative disorder
that has a profound impact on individuals, their family,
and society. As dementia progresses, functional ability
and cognitive function decline with a consequent in-
crease in the amount of care required [1]. This can lead
to substantial personal and societal costs [2]. During the
course of the illness other complications can arise un-
predictably including neuropsychiatric symptoms such
as agitation, aggression, depression and anxiety [3, 4].
In the UK it is estimated that, in terms of severity, just
over half of people with dementia (55.4%) have mild de-
mentia, 32.1% have moderate dementia, and 12.5% have
severe dementia [5]. Understanding the impact of dis-
ease severity on dementia -related outcomes is import-
ant to enable the development and delivery of treatment
and care that allows people to live well with dementia
and for families and healthcare providers to respond to
changes as the disease progresses. The goal of such care
is to maintain and enhance the quality of life (QoL) of
the person with dementia and this is therefore a key out-
come to understand and measure. Understanding the
impact of disease severity on carer-related outcomes is
equally as important as it ensures that the carer’s own
QoL does not suffer as a result of the inevitable deterior-
ation of the person for whom they provide care.
Quality of life is a multidimensional construct that in-
corporates an “individual’s perception of their position in
life in the context of culture and value systems in which
they live and in relation to their goals, expectations, stan-
dards, and concerns” (pg 1405) [6]. For people with de-
mentia, demographic factors do not appear to have a
strong effect on QoL [7–9]; instead neuropsychiatric
symptoms (e.g. depression) appear to account for greater
proportions of variance [9–11]. Intuitively, we may assume
that as the severity of dementia increases, exemplified by
cognitive and functional decline, so does the QoL of the
person with dementia decline. However, reviews of the lit-
erature have found mixed evidence about the relationship
between QoL and severity of cognitive impairment in
people with dementia [8, 12], with some authors finding
that increased cognitive impairment predicts lower QoL
[13], whilst others have found no such relationship [14]. It
has previously been suggested that such differences in
findings could be explained in part by the use of self-
report versus proxy-report measures of QoL [8].
Similarly, it has also been assumed that increasing dis-
ease severity would negatively impact on family carer
QoL, due to changes in personal freedom of the carer,
practical demands, and its impact on the interpersonal
relationship [15]. There is less literature in the field of
carer QoL, but again to date most studies have (appar-
ently paradoxically) found no association between carer
QoL and the severity of cognitive impairment of the per-
son with dementia [16]. Instead, factors such as behav-
ioural problems, carer burden and depression appear to
be more consistently associated with carer QoL [16–18]
However, there may be an indirect effect between dis-
ease severity and carer QoL through increasing carer
burden and depression [19].
The MODEM programme was designed to model how
changes in the treatment and care of people with de-
mentia, and support for carers, can result in better out-
comes [20]. One element of this was the collection of
new, high-quality, one-year cohort data from people
with dementia and their carers. Participants were pur-
posively recruited to capture samples balanced in num-
bers across disease severity, based on cognitive
impairment. Unlike many previous studies, we sought to
capture a range of measures of QoL because one pur-
pose of the cohort study was to collect data that would
allow cross-walk between measures used in epidemio-
logical surveys and in clinical evaluations.
In this paper we investigate the baseline characteristics
of the MODEM cohort, with a focus on understanding
the relationship between disease severity and the QoL of
the person with dementia and their carer. It was
hypothesised that dementia severity would not be associ-
ated with the QoL of the person with dementia or their
carer after controlling for confounding variables.
Methods
Design
Cross-sectional baseline data from a cohort study.
Participants
Participants had a medical diagnosis of dementia made
by a specialist mental health service. We aimed to
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recruit 100 people with mild (scoring 20+ on the stan-
dardised Mini-Mental State Examination), 100 with
moderate (score 10–19), and 100 with severe cognitive
impairment (score 0–9). These severity categories are in
line with recommendations for categorising moderate
and severe dementia using the sMMSE [21]. To be eli-
gible the person with dementia needed to have an identi-
fiable family (or friend) carer or other informant (e.g. a
formal/professional carer). There were no exclusion cri-
teria based on comorbidities, age, or type of dementia.
The carer required to self-identify themselves as a carer
for the person with dementia, there were no other inclu-
sion or exclusion criteria. Participants were recruited
from memory services in Sussex, UK, or self-referral
from a national electronic database (Join Dementia Re-
search; https://www.joindementiaresearch.nihr.ac.uk/),
community groups, and care homes in the South East of
England.
Procedure
People with dementia and their carers were provided
with information about the research and invited to par-
ticipate in the study. A pair of researchers then visited
the participants in their home (or another location con-
venient for the participant). The capacity of the person
with dementia was formally assessed by a trained re-
searcher. A form was also completed, which guided the
researcher to make judgements on whether the partici-
pant was a) able to understand the purpose of the study,
b) able to retain the information long enough to make a
decision, c) able to weigh up the information in order to
make a decision, and d) able to communicate their deci-
sion. If the person with dementia did not have capacity
to consent, a personal consultee (family member/friend)
was identified to advise on whether the person with de-
mentia should take part. For those with capacity, in-
formed consent was obtained. The two researchers then
completed a series of measures with the person with de-
mentia and the carer in parallel. Additional context and
an overview of the methods have been reported else-
where [20]. Ethical Approval was obtained by the Social
Care Research Ethics Committee (15/IEC08/0005).
Measures
The following measures were completed. They can be
divided into three response formats: 1) person with de-
mentia completed measures about themselves, 2) carer
completed about the person with dementia, and 3) carer
completed about themselves. Broadly, QoL can be mea-
sured using either generic or disease-specific strategies
[22]. The generic strategy uses instruments applicable
across different diseases and treatments, at the cost of
perhaps failing to address disease-specific elements that
may be crucial to QoL in a given condition, so being less
sensitive in detecting changes in outcome [22, 23].
Disease-specific approaches can complement these gen-
eric outcomes by providing insight into the complex na-
ture of the condition, which might change as the disease
progresses [14, 24, 25].
Self-report measures of QoL (person with dementia)
1. DEMQOL [26] – 28 item interviewer-administered
questionnaire answered by the individual with de-
mentia, a dementia-specific health-related QoL
measure. DEMQOL data were collected for mild
and moderate dementia as per its instructions for
use. The measure was developed for use in people
with dementia, has good internal consistency (α =
0.87) and moderate convergent validity [24, 26].
The total score of the DEMQOL ranges from 28 to
112, with higher scores representing better QoL.
2. EQ-5D-3L [27] – a 5 item, self-report questionnaire
on generic health related QoL. The EQ-5D-3L is
able to distinguish between healthy and a range of
disease groups [28]. The self-report measure has
been shown to be feasible for use within people
with mild-to-moderate dementia [29]. A summary
index score was calculated using country-specific
value sets, which generally range from 0 (death) to
1 (perfect health). Data were not collected for those
with severe dementia.
3. CASP-19 [30] – a 19 item, self-report measure of
QoL comprising four domains (control, autonomy,
self-realisation and pleasure). In people with demen-
tia, the CASP-19 display good overall internal
consistency (α = 0.86) and correlates with an estab-
lished measure of QoL (r = 0.71) [31]. Individual
items are summed together and range from 0 to 57,
in which higher scores represent a “total satisfaction
of control, autonomy, self-realization and pleasure
domains”. Data were not collected for those with
severe dementia.
Proxy-report measures of QoL (person with dementia)
1. DEMQOL-Proxy [26] – 31 item interviewer-
administered questionnaire answered by the carer
on the individual with dementia, a dementia-
specific health-related QoL measure. The measure
demonstrates high internal consistency in mild-
moderate severity dementia (α = 0.87) and in severe
dementia (α =0.92) [26]. Individual items are
summed to create a total score (Range: 31–124),
with higher scores representing better QoL.
2. EQ-5D-3L [27] – a 5 item, proxy-report question-
naire on generic health related quality of life. Inter-
rater agreement between the self-and proxy report
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version of the EQ-5D-3L are typically quite low
[29]. See above for further details about the EQ-5D-
3L measure.
Self-report measures of QoL (Carer)
1. EQ-5D-3L [27]– a 5 item, self-report questionnaire
on generic health related quality of life. See above
for further details about the EQ-5D-3L measure.
2. Short Form Health Survey (SF-12) [32] – a 12 item
questionnaire to measure generic health related
quality of life. Two summary measures are
calculated, the physical health and mental health
domain, both of which have shown to have high
internal consistency across populations (e.g. α = 0.85
and 0.83, respectively in an elderly population) [33].
SF-12 summary scores each range from 0 to 100,
with 100 indicate the highest level of health.
Other measures
1. Standardized Mini-Mental State Examination
(sMMSE) [34] - a brief, global measure of cognitive
function. The MMSE generally displays good in-
ternal consistency (e.g. α = 0.70) [35] and maps onto
dedicated dementia staging questionnaires such as
the Clinical Dementia Rating scale [36, 37]. The
sMMSE is a standardized version of the MMSE, in
terms of how it is administered and scored. Correct
items are summed to create a total score ranging
from 0 to 30, with lower scores representing greater
cognitive impairment and severity.
2. Zarit Carer Burden Inventory (ZCBI) [38] – a 22
item scale to measure carer burden. The
questionnaire has a high internal consistency in
carers of people with dementia (α = 0.90) [39].
Individual items are summed (Range: 0–88), with
higher scores reflect greater carer burden.
3. Neuropsychiatric Inventory (NPI) [40, 41] – an
instrument to record presence of 10 behavioural
and psychological symptoms in dementia. The total
score has a high level of internal consistency (α =
0.88), and displays an good level of concurrent
validity with an existing validated measure of
behavioural and psychological symptoms in
dementia [41]. The total score is calculated by
multiplying frequency by severity for each domain,
and summing them together. Higher scores
represent more behavioural and psychological
symptoms (Range: 0–120).
Analysis
The mean and standard deviation (SD) were reported
for continuous data, frequencies and percentages were
reported for categorical data. All descriptive data were
split by severity (sMMSE total score: 20–30 =mild; 10–
19 =moderate; 0–9 = severe). Preliminary between group
analyses were completed using a Pearson’s Chi Square
test for categorical data, and an ANOVA or Student’s t-
test for continuous data (three-group and two-group
comparisons, respectively).
QoL was our primary domain of interest, captured
through a battery of self-reports (DEMQOL, EQ-5D,
CASP-19) and proxy-reports (DEMQOL-Proxy, EQ-5D)
of disease-specific and generic QoL for the person with
dementia, and generic self-reported QoL (EQ-5D, SF-12)
for carers. We completed a Pearson’s correlation analysis
between outcomes to explore how they were associated
with one another. We then identified whether the associ-
ations remained significant following correction for mul-
tiple comparisons [42].
A series of multiple regression models were created, in
which QoL outcomes were the dependent variables. In
each model, factors were entered into three stages. At
Stage 1, a simple model was created with sMMSE as the
only independent variable. At Stage 2, control variables
were entered into the model to control for their effects,
without the presence of sMMSE. At Stage 3, the sMMSE
scores were entered in the model following the control
variables. This allowed us to identify the amount of ex-
plained variance in severity after accounting for the con-
trol variables.
For analyses of the QoL of people with dementia, vari-
ables entered in Stage 2 were age of the person with de-
mentia, their gender, neuropsychiatric symptoms (NPI
total score), carer QoL (EQ-5D) and residential setting.
For carer QoL outcomes, the following variables were
entered in Stage 2; carer age, carer gender, relationship
with person with dementia, residential setting of the per-
son with dementia, neuropsychiatric symptoms of the
person with dementia, carer burden (ZCBI), and the
QoL of person with dementia (DEMQOL-Proxy). Keep-
ing the variables consistent between models within out-
come themes allowed us to compare the differential role
of disease severity.
Variables entered in the model were selected on the
basis on existing evidence, and consensus within the ex-
perienced research team. In selecting the measures, we
were conscious that we wanted to control for key con-
founding effects, rather than build a “best fit” model. As
such, we avoided the use of step-wise regression, which
is susceptible to inflating type I error [43], or including
all potentially confounding variables with the risk of
over-fitting the model [44].
We visually inspected regression outputs (e.g. P-P plot)
for evidence of normality of residuals of the regression
and homoscedasticity. Multicollinearity was checked be-
tween independent variables prior to building the
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models: a Variance Inflation Factor (VIF) threshold of 10
was used to indicate probable multicollinearity [45].
There were no instances of the VIF exceeding 3.
Missing values within standardised questionnaires
were handled in accordance with measure guidance,
when available. Listwise deletion was adopted across
analyses in the case of missing values. Statistical signifi-
cance was defined as a p value < 0.05. All data were ana-
lysed in SPSS V.25.
Results
Three hundred and seven participant dyads were con-
sented into the study. Of those with dementia, 110 were
classified as having mild dementia, 100 moderate, and 97
severe. On average participants had a sMMSE of 14.9
(SD = 9.08). 155 (50.5%) of the people with dementia
were female, the average age of the sample was 80.9
years old (SD = 8.42) and most were diagnosed with Alz-
heimer’s disease (n = 176, 60.7%). Carers tended to be fe-
male (n = 202, 65.8%), spousal carers (n = 198, 64.7%),
and their average age was 69.2 years (SD = 11.45). For
detail of demographic and other key variables, please see
Tables 1 and 2.
Table 3 presents correlations between the QoL mea-
sures used for people with dementia and carers. For self-
report of QoL by the person with dementia (DEMQOL,
CASP-19, EQ-5D) there were statistically significant cor-
relations between all measures (p < 0.001) which
remained statistically significant after correcting for mul-
tiple comparisons (Holm-Bonferroni Sequential Correc-
tion, p < 0.05). For proxy-reports, the disease-specific
measure DEMQOL-Proxy was statistically significantly
correlated with all self-report measures of the QoL of
the person with dementia (DEMQOL, EQ-5D, CASP-19)
at the p < 0.001 level, with this remaining after correc-
tion for multiple comparison. The generic proxy meas-
ure (EQ-5D) was correlated statistically significantly
univariately with all the self- and proxy-reported instru-
ments (DEMQOL, EQ-5D (self), CASP-19 (self),
DEMQOL-Proxy), but when correction for multiple
comparison was applied the association with CASP-19
(self) and DEMQOL-Proxy did not reach statistical
significance.
For carer QoL, the carer EQ-5D score and SF-12 men-
tal sub-score were statistically significantly (after mul-
tiple comparison correction) associated with the
DEMQOL-Proxy score for the person with dementia.
Table 1 Person with dementia, descriptive data by severity of cognitive impairment
Mild Moderate Severe Sig. Test
Age, mean (SD) 80.2 (7.2) 82.4 (8.8) 80.0 (9.2) F = 2.50, p = 0.08
Gender: male, N (%) 62 (56.4%) 55 (55.6%) 34 (35.1%) χ2 = 11.62, p = 0.003
Residential status: care home (v own household), N (%) 6 (5.5%) 17 (17.0%) 40 (41.2%) χ2 = 41.59, p < 0.0001
Ethnicity: White British, N (%) 105 (96.3%) 88 (89.8%) 88 (90.7%) χ2 = 13.03, p = 0.37
Diagnosis: χ2 = 4.28, p = 0.83
AD, N (%) 63 (63.0%) 55 (57.9%) 58 (61.1%)
VaD, N (%) 13 (13.0%) 12 (12.6%) 14 (14.7%)
LBD, N (%) 2 (2.0%) 1 (1.1%) 3 (3.2%)
FTD, N (%) 4 (4.0%) 4 (4.2%) 1 (1.1%)
Other, N (%) 18 (18.0%) 23 (24.2%) 19 (20.0%)
sMMSE (↑ better cognition), mean (SD) 24.6 (0.2) 15.1 (2.9) 3.6 (3.2) F = 1360.36, p < 0.0001
QOL SELF-REPORT
DEMQOL (↑ better QoL), mean (SD) 90.5 (13.18) 92.8 (12.6) – t = −1.23, p = 0.22
CASP total (↑ better QoL), mean (SD) 40.9 (9.5) 40.1 (8.0) – t = 0.58 p = 0.61
EQ-5D Index (↑ better QoL), mean (SD) 0.8 (0.2) 0.8 (0.2) – t = −0.08, p = 0.94
QOL PROXY-REPORT
DEMQOL-Proxy (↑ better QoL), mean (SD) 93.5 (13.7) 94.3 (14.4) 98.1 (13.0) F = 3.18, p = 0.04
EQ-5D-proxy Index (↑ better QoL), mean (SD) 0.7 (0.3) 0.5 (0.3) 0.4 (0.3) F = 26.76, p < 0.0001
COMORBIDITIES
NPI total (↑ more neuropsychiatric symptoms), mean (SD) 12.7 (11.0) 20.1 (15.5) 24.1 (16.3) F = 15.51, p < 0.0001
AD Alzheimer’s Disease, BADL Bristol Activities of Daily Living, CCI Charlson Comorbidity Index, FTD Frontotemporal Dementia, LBD Lewy Body Dementia, NPI
Neuropsychiatric Inventory, QoL Quality of Life, sMMSE standardised Mini-Mental State Examination, OARS Older Adult Social Resource Scale, VaD
Vascular Dementia
F = F statistic derived from one-way Analysis of Variance, t = t value derived from t-test, χ2 = Chi-square value derived from a Pearson’s Chi-square test
Farina et al. BMC Geriatrics          (2020) 20:232 Page 5 of 13
The only other correlation that persisted after correction
was between the carer EQ-5D and SF-12 physical and
mental sub-scores.
Person with dementia quality of life (self-report)
Dementia severity as measured by the sMMSE did not
significantly contribute to explanation of variation in
DEMQOL scores in the uncontrolled model (β = − 0.12,
p = 0.09). After controlling for other variables, sMMSE
still did not significantly contribute to DEMQOL scores,
accounting for only 2% of variance (β = − 0.15, ΔR2 =
0.02, p = 0.06). No covariates were significantly associ-
ated with DEMQOL scores. See Table 4.
Dementia severity was not significantly associated with
self-report EQ-5D scores in the uncontrolled model (β =
− 0.02, p = 0.83). Dementia severity did not significantly
account for variance of the self-report EQ-5D after con-
trolling for confounding variables (β = − 0.04, ΔR2 =
0.001, p = 0.63). No variables within the model were sig-
nificantly associated with self-report EQ-5D scores. See
Table 4.
Dementia severity was not significantly associated with
CASP-19 scores in the uncontrolled model (β = 0.04, p =
0.64). For the CASP-19, dementia severity again did not
significantly account for variance in the model after ac-
counting for control variables (β = − 0.01, ΔR2 < 0.001,
p = 0.89). Only age was significantly associated with
CASP-19 scores in the model, with older age being asso-
ciated with improved QoL (β = 0.21, p = 0.02). See Table
4.
Person with dementia quality of life (proxy-report)
The uncontrolled model revealed that sMMSE scores
were negatively associated with DEMQOL-Proxy scores
(β = − 0.18, p = 0.001). Severity was associated with
DEMQOL-Proxy scores, accounting for 6% of variance
in the controlled model (β = − 0.29, ΔR2 = 0.06, p <
0.001). Worse cognitive function was associated with sig-
nificantly higher DEMQOL-Proxy scores within the
model, indicating that QoL by proxy assessment was
higher in the groups of people with more severe demen-
tia. There was a significant negative association between
DEMQOL-Proxy scores and NPI scores (β = − 0.43, p <
Table 2 Carer, descriptive data by severity of cognitive impairment
Mild Moderate Severe Sig. Test
Age, mean (SD) 71.5 (12.0) 68.7 (11.4) 67.3 (10.6) F = 3.64, p = 0.03
Gender: male, N (%) 32 (29.4%) 26 (26.5%) 44 (45.4%) χ2 = 9.09, p = 0.01
Ethnicity: White British, N (%) 106 (98.1%) 90 (91.8%) 89 (94.1%) χ2 = 11.38, p = 0.33
Live with person with dementia: Yes, N (%) 87 (79.8%) 66 (67.3%) 50 (51.5%) χ2 = 18.51, p < 0.001
Relationship to Person with dementia: Spousal, N (%) 84 (76.4%) 60 (60.6%) 54 (55.7%) χ2 = 13.43, P = 0.009
Zarit Carer Burden Inventory (↑ greater burden), mean (SD) 28.6 (13.9) 32.0 (16.2) 29.5 (15.7) F = 1.40, p = 0.25
EQ-5D self (↑ better QoL), mean (SD) 0.8 (0.2) 0.8 (0.3) 0.9 (0.2) F = 2.00, p = 0.14
SF-12: Physical (↑ better health/QoL), mean (SD) 48.2 (11.5) 46.9 (12.4) 49.4 (10.8) F = 1.11, p = 0.33
SF-12: Mental (↑ better health/QoL), mean (SD) 47.9 (10.2) 45.3 (10.0) 46.8 (11.0) F = 1.49, p = 0.23
GHQ General Health Questionnaire
F = F statistic derived from one-way Analysis of Variance, t = t value derived from t-test, χ2 = Chi-square value derived from a Pearson’s Chi-square test
Table 3 Correlations between person with dementia and carer QoL measures (Pearson’s r and p-values)
Person with dementia Carer (all self-reports)
EQ-5D (self) CASP-19 (self) DEMQOL-
Proxy














0.36 (p < 0.001) 0.12 (p = 0.09) 0.14 (p = 0.06) 0.18 (p = 0.02)
CASP-19 (self) 0.33
(p < 0.001)
0.21 (p = 0.01) 0.09 (p = 0.29) 0.11 (p = 0.19) 0.06 (p = 0.49)
DEMQOL-Proxy 0.16 (p = 0.005) 0.20 (p = 0.001) 0.13 (p = 0.03) 0.31 (p = < 0.001)
EQ-5D (proxy) 0.02 (p = 0.77) −0.01 (p = 0.92) 0.07 (p = 0.28)
Carer EQ-5D 0.71 (p < 0.001) 0.25 (p < 0.001)
SF-12 Physical −0.05 (p = 0.41)
Statistics in bold highlight remained significant after correcting for multiple comparisons (Holm-Bonferroni Sequential Correction, p < 0.05)
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Table 4 Multiple regression models with person with dementia QoL outcomes as dependent variables. The model fit is reported for
each model, and the contribution of disease severity (sMMSE) reported (ΔR2 and p-value). Individual variables beta coefficients
(including 95% CIs) are also reported
Coefficients Model change Model
Model Independent Variables β B B Lower 95% CI B Upper 95% CI p ΔR2 p Adjusted R2 F p
DEMQOL
(n = 177)
0.02 0.06 0.04 2.19 0.05
Gender: Male −0.11 −2.97 −6.92 0.98 0.14
Residential setting:
Care home
−0.13 −5.26 −11.73 1.22 0.11
Age 0.15 0.24 −0.01 0.49 0.06
NPI − 0.05 −0.05 −0.19 0.09 0.49
Carer EQ-5D 0.07 3.51 −3.81 10.84 0.35
sMMSE −0.15 −0.37 −0.76 0.01 0.06
EQ-5D (self)
(n = 185)
0.001 0.63 0.00 0.99 0.43
Gender: Male −0.03 − 0.01 − 0.08 0.06 0.75
Residential setting:
Care home
−0.01 0.00 −0.12 0.11 0.95
Age 0.04 0.00 0.00 0.01 0.60
NPI −0.13 0.00 0.00 0.00 0.09
Carer EQ-5D 0.10 0.09 −0.05 0.22 0.21
sMMSE −0.04 0.00 −0.01 0.00 0.63
CASP-19 (self)
(n = 155)
< 0.001 0.89 0.03 1.63 0.14
Gender: Male −0.10 −1.81 −4.91 1.29 0.25
Residential setting:
Care home
−0.12 −3.98 −9.73 1.77 0.17
Age 0.21 0.25 0.05 0.45 0.02
NPI −0.10 −0.07 −0.20 0.06 0.27
Carer EQ-5D 0.02 0.61 −5.26 6.47 0.84
sMMSE 0.01 0.02 −0.29 0.34 0.89
DEMQOL-Proxy
(n = 284)
0.06 < 0.001 0.22 14.14 < 0.001
Gender: Male 0.07 2.01 −0.96 4.98 0.18
Residential setting:
Care home
−0.01 −0.39 −4.52 3.75 0.85
Age 0.00 0.01 −0.17 0.19 0.95
NPI −0.43 −0.39 −0.49 − 0.29 0.00
Carer EQ-5D 0.14 8.11 2.09 14.13 0.01
sMMSE −0.29 −0.44 −0.62 − 0.26 0.00
EQ-5D (proxy)
(n = 276)
0.04 < 0.001 0.25 16.36 < 0.001
Gender: Male 0.13 0.08 0.01 0.15 0.02
Residential setting:
Care home
−0.16 −0.13 −0.23 −0.03 0.01
Age −0.13 − 0.01 −0.01 0.00 0.02
NPI −0.26 −0.01 −0.01 0.00 0.00
Carer EQ-5D 0.08 0.10 −0.04 0.24 0.15
sMMSE 0.23 0.01 0.00 0.01 0.00
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0.001) with higher levels of neuropsychiatric symptoms
associated with lower QoL for the person with dementia
and carer self-reported QoL (β = 0.14, p = 0.01). See
Table 4.
Severity was also statistically significantly associated
with proxy-reported EQ-5D scores in both the uncon-
trolled (β = 0.42, p < 0.001) and controlled model
(β = 0.23, ΔR2 = 0.04, p < 0.001). Participants with better
cognitive function had significantly higher EQ-5D Proxy
scores. See Table 4. Within the model, being older (β =
− 0.13, p = 0.02), living in a care home (β = − 0.16, p =
0.01), and having neuropsychiatric symptoms (β = − 0.26,
p < 0.001) were significantly associated with poorer QoL
as measured by the proxy-report EQ-5D. Whilst being
male was associated with better QoL scores (β = 0.13,
p = 0.02). This suggests differential functioning of
disease-specific and generic QoL measures.
Carer quality of life
Severity of dementia was significantly associated with
carer self-report EQ-5D, in the absence of control vari-
ables (β = − 0.13, p = 0.03). This association did not re-
main significant after controlling for confounding
variables, explaining only 1% of the variance (β = − 0.09,
ΔR2 = 0.01, p = 0.19). Within the model, carer burden
was significantly negatively associated with EQ-5D (β =
− 0.28, p < 0.001; i.e. the higher the carer burden the
lower the QoL). The QoL of the person with dementia
was also positively associated with EQ-5D in the model
(β = 0.14, p = 0.03). No other variable was significantly
associated with carer EQ-5D in the model. See Table 5.
For the SF-12, severity did not significantly account
for variance of either physical (β = − 0.08, p = 0.19) or
mental health domains (β = 0.01, p = 0.93) in the uncon-
trolled models. After controlling for confounding vari-
ables, both physical (β = − 0.06, p = 0.37) and mental
health (β = 0.002, p = 0.97) each accounted for less than
1% of variance. For the mental health domain, carer age
(β = 0.16, p = 0.02), carer burden (β = − 0.57, p < 0.001),
and DEMQOL-Proxy (β = 0.13, p = 0.02) were all signifi-
cantly associated with the outcome. Only carer age (β =
− 0.17, p = 0.04) and carer burden (β = − 0.16, p = 0.02)
were significantly associated with the SF-12 physical do-
main. See Table 5.
Discussion
This study adds to the literature by taking multiple as-
sessments of the QoL of people with dementia and their
carers, and examining their association with severity of
dementia (as measured by severity of cognitive impair-
ment). Our analyses support the somewhat counterintui-
tive argument that severity of cognitive impairment (and
therefore severity of dementia) is not associated with
lower QoL for the person with dementia when self-
report measures are used. The data suggest that, after
controlling for key variables, the QoL of people with
dementia may even improve as the condition deterio-
rates. However, this was only statistically significant in a
single proxy-report measure (DEMQOL-Proxy) and
approached significance (p = 0.06) in a single self-report
measure (DEMQOL). Proxy measures (rated by the
carer) differed systematically in that there were small
but statistically significant proportions of the variance of
QoL explained by severity of cognitive impairment in
multiple adjusted models. Previous research has indeed
found that proxy-reported outcomes tend to differ to
self-report outcomes, with the proxies reporting more
health and functional impairments [46, 47]. There are
three main possible reasons for this. First, the greater
range of severity of dementia that can be included using
proxy measures (self-reports were only possible in the
mild and moderate severity groups) means that particu-
lar harms that may accrue in the very latest stages of de-
mentia may contribute to the findings. Second there is
known error in making proxy assessments of another’s
QoL, and it may be that such proxy assessments are
over-influenced by the intuitive belief that increasing se-
verity of dementia must have a negative impact on the
person with dementia. Third, it is likely that lack of
insight, or lack of engagement with their illness, could
result in people with dementia under-reporting reduced
QoL. Certainly, impaired insight provides less reliable
ratings of QoL [48], and may even effect the reliability
and validity of some self-report measures of QoL [49].
However, in absolute terms, as judged by the variance in
the multivariate models, it is clear that the contribution
of dementia severity to the QoL of people with dementia
is minimal whatever the measurement used, be it self- or
proxy-rated, or disease-specific or generic. Similarly,
when examining the relationship between carer QoL and
severity of dementia, in multivariate analyses there were
no associations between greater dementia severity and
lower carer QoL as measured by the EQ-5D or SF-12,
with the variance largely driven by the severity of carer
burden. We also found little in the way of statistically
significant relationships between the QoL of people with
dementia and that of their carers except between
DEMQOL-Proxy scores and the carer EQ-5D scores and
carer SF-12 mental sub-scores.
The finding that severity is not associated with
dementia-specific measures of QoL supports previous evi-
dence both cross-sectionally and longitudinally [50–52].
While there was no association with severity in self-report
measures, proxy-report measures of QoL (DEMQOL-
Proxy and proxy-report EQ-5D) did show a statistically
significant association with severity. As noted above, proxy
measures are of particular importance in studies of people
with more severe dementia because of greater difficulties
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with self-report. For example, DEMQOL’s psychometrics
are strong for those with mild and moderate dementia but
not for those with severe dementia, so it cannot be used
reliably in those with severe cognitive impairment [26]. As
such, for people with severe dementia, we are unable to
know the associations between the score of sMMSE with
their self-reported QoL. Limitations in awareness of cog-
nitive impairment, or lack of insight, are often cited as rea-
sons why self-reported QoL does not decline as disease
severity increases, with older adults who are aware of their
dementia diagnosis rating their QoL lower than those that
were unaware [53]. This is in line with previous literature
that highlights the effect of awareness of disease and de-
pressive symptoms on self-report QoL scores [54].
However, even with limitations in insight, these self-
appraisals of QoL may well be valid. People with dementia
may not be much concerned with gradual deterioration in
cognitive and physical function to which they and their
families have been able to adapt. This is in line with the
findings of adaptation to other long-term conditions with
subsequent high life quality, often termed ‘the disability
paradox’ [55]. Discrepancies between DEMQOL-Proxy
and proxy EQ-5D may be due to the nature of the mea-
sures, since EQ-5D focusses on functionality and ability,
rather than emotional responses in DEMQOL-Proxy. In
this way, the EQ-5D may act as a measure of function,
which undoubtedly declines with increasing cognitive im-
pairment, rather than QoL, which may not. The
Table 5 Multiple regression models with carer-related QoL measures as dependent variables. The model fit is reported for each
model, and the contribution of disease severity (sMMSE) reported (ΔR2 and p-value). Individual variables beta coefficients (including
95% CIs) are also reported
Coefficients Model change Model
Model Independent variables β B B Lower 95% CI B Upper 95% CI p ΔR2 p Adjusted R2 F p
EQ-5D carer
(n = 213)
0.01 0.19 0.12 5.83 < 0.001
Carer gender: Male 0.08 0.04 −0.02 0.10 0.19
Residential setting:
Care home
−0.09 − 0.05 −0.13 0.03 0.19
Carer age −0.13 0.00 −0.01 0.00 0.10
Relationship: Spouse −0.04 −0.02 −0.10 0.07 0.66
NPI 0.08 0.00 0.00 0.00 0.24
ZCBI −0.28 −0.01 −0.01 −0.00 0.00
DEMQOL-Proxy 0.14 0.00 0.00 0.01 0.03 `
sMMSE −0.09 −0.00 −0.01 0.00 0.19
SF-12 Physical Health
(n = 273)
0.003 0.37 0.05 2.80 0.01
Carer gender: Male 0.02 0.54 −2.47 3.54 0.72
Residential setting:
Care home
−0.12 −3.44 −7.64 0.75 0.11
Carer age −0.17 −0.18 − 0.35 −0.01 0.04
Relationship: Spouse −0.03 −0.79 −5.09 3.52 0.72
NPI 0.03 0.02 −0.10 0.14 0.70
ZCBI −0.16 −0.13 −0.23 − 0.02 0.02
DEMQOL-Proxy 0.09 0.08 −0.04 0.19 0.18
sMMSE −0.0 −0.08 −0.27 0.10 0.37
SF-12 Mental Health
(n = 273)
< 0.001 0.97 0.43 26.56 < 0.001
Carer gender: Male 0.07 1.57 −0.50 3.64 0.14
Residential setting:
Care home
−0.09 −2.46 −5.35 0.43 0.10
Carer age 0.16 0.14 0.02 0.26 0.02
Relationship: Spouse −0.05 −1.03 −3.99 1.94 0.50
NPI −0.07 −0.05 −0.13 0.03 0.22
ZCBI −0.57 −0.39 −0.46 − 0.32 0.00
DEMQOL-Proxy 0.13 0.10 0.02 0.18 0.02
sMMSE 0.00 0.00 −0.13 0.13 0.97
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differences in what is actually measured may also explain
the weak association between the two measures (r = 0.16).
Such emphasis on functional ability when measuring QoL
using generic measures and those not developed and vali-
dated for dementia has been criticised elsewhere [56].
Neuropsychiatric symptoms, as measured by the NPI,
were significantly associated with scores across all
proxy-report QoL instruments, but not in self-report
QoL instruments. This is in line with previous findings
which are either negative [8, 57], or account for only a
small amount of variance [7]. A recent meta-analysis of
the literature found that neuropsychiatric symptoms
showed a moderate association with poorer QoL, irre-
spective of rating type [52]. However, as noted by Naglie
and colleagues, certain QoL measures may be more sen-
sitive than others [58].
For carer QoL, severity of cognitive impairment in the
person with dementia was not significantly associated
with scores, accounting for less than 2% of variance
within the models. The only factor across carer QoL
outcome measures to be consistently associated with
carer QoL was the ZCBI which is a measure of subject-
ive carer burden. This is in line with the literature that
consistently shows a negative association between carer
QoL and subjective reports of carer burden [16]. This in-
dicates that the carer’s perceived burden of care may be
a more important factor in determining QoL than sever-
ity of dementia alone, and therefore supporting carers is
paramount to maintain good carer QoL.
Carer QoL was significantly associated with age (SF-
12 physical and mental health domains). Interestingly
age was positively associated with carer QoL in the
mental health domain, but negatively associated with
physical health domain. These same associations have
been reported elsewhere [59–61], although it is still
unclear whether this is due to differential item func-
tioning (e.g. different interpretation of items and dif-
ferences in response style). Carer QoL (EQ-5D and
SF-12 mental health domain) was significantly associ-
ated with the QoL of the person with dementia, sup-
porting previous findings [17, 62–64]. However, as
previously highlighted, there may be an element of re-
verse causality, because carers may project their own
QoL and health state into their assessment of the
person with dementia [16].
A strength of this paper is the simultaneous use of a
number of QoL tools. In MODEM, we used both generic
QoL measures (EQ-5D and CASP) and disease-specific
measures of QoL (DEMQOL, DEMQOL-Proxy). How-
ever, due to an absence of robustly developed disease-
specific carer QoL outcomes specific to dementia [65]
only generic measures of carer QoL were available. This
supports a need for dementia-specific carer QoL out-
come measures.
An important limitation of the study is that the people
with dementia and the carers recruited were predomin-
antly White British (92.4 and 94.1% respectively). While
this reflects the general population of older adults in Eng-
land and Wales [66], the relative lack of ethnic diversity
limits the generalisability of our findings, particularly to
other cultures and countries. Results reported here reflect
a modest sample of people with dementia (and their
carers) who were motivated to participate in this research
project within South East England. The study does not in-
clude people with dementia who do not have a carer, and
whilst this would have prevented proxy-report measure-
ment, we are unable to comment whether dementia sever-
ity would differentially effect those that are living
independently. We did not capture the response rate to
the study, and therefore unable to directly quantify any
non-response bias introduced. It is also important to rec-
ognise that these findings only describe a cross-sectional
relationship between severity and QoL; the analyses need
to be replicated longitudinally to investigate the effects of
the progressive nature of dementia.
The models presented here should not be considered
as definitive models of factors associated with QoL.
There are potentially other variables that could have
accounted for additional variance within each model
(e.g. insight [67]). This is particularly the case for self-
report QoL measures of people with dementia, where
very little variance (< 5%) is accounted for. Finally, it
should be noted that the use of sMMSE as the measure
of severity could be considered a limitation. The sMMSE
measures cognitive impairment, rather than dementia
severity specifically, although obviously the two are
closely linked, with the MMSE mapping onto measures
of severity [36, 37]. Despite MMSE being widely
adopted, it has received criticism, such as not being
education-fair, and suffering from floor and ceiling ef-
fects [68–71].
Conclusions
Our findings highlight the complex relationship between
severity of dementia and QoL in people living with de-
mentia and their carers. They highlight the effect of tool
selection of outcomes. Proxy-report measures of
dementia-specific QoL are more strongly associated with
dementia severity. It may well be that relatively slow de-
terioration in dementia allows for the processes of adap-
tation seen in other disabilities to allow people with
severe dementia to live as a good quality of life as those
with less severe dementia. We see the same picture in
relation to carer QoL: increased severity of impairment
of the person with dementia does not necessarily mean
poorer carer QoL, and instead factors such as carer bur-
den play a much greater central role.
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